Theramix LLC
Biotech · Private
A real-time cellular damage mapping reporter system for toxicological screening in whole animals
- Grants
- $911K
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A new imaging-based rapid in vivo toxicological screening method | $217,130 | |
| Federal grant | Department of Health and Human Services · Phase I · Creating a bioluminescent mouse model for fast screening of drugs | $217,130 | |
| Federal grant | Department of Health and Human Services · Phase I · Creating a bioluminescent mouse model for fast screening of drugs | $217,130 | |
| Federal grant | Department of Health and Human Services · Phase I · Toxicological screening in a single animal format | $259,613 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2935 | QUANTUMBIO INC | — | — |
| 2936 | CBS THERAPEUTICS, INC. | — | — |
| 2937 | Dayra Therapeutics | — | — |
| 2938 | Theramix LLC | — | — |
| 2939 | Barricade Therapeutics Corp | — | $100K |
| 2940 | Surf Bucket, Inc | — | $10K |
| 2941 | DISCO Pharmaceuticals | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.